Veronica Ranieri
Papers
2
Total Citations
42
H-Index
2
About
Dr. Veronica Ranieri is a leading clinical researcher in urologic oncology, whose work is reshaping the management of small renal masses (SRMs). Her primary research focus lies in conducting high-quality, comparative effectiveness trials to determine the optimal, nephron-sparing treatment for kidney cancer. Dr. Ranieri is the principal investigator behind the landmark NEST (Nephron Sparing Treatment) feasibility trial, which directly compares percutaneous cryoablation to robot-assisted partial nephrectomy. Her major contribution is addressing a critical evidence gap: the historical lack of randomized controlled trial data in this field due to poor patient recruitment. By successfully demonstrating the feasibility of a cohort-embedded RCT design, she has paved the way for definitive trials that could establish a new standard of care. Her protocol and results papers, each garnering 21 citations, are foundational references for researchers and clinicians navigating the challenge of comparing surgical and ablative techniques. Dr. Ranieri’s work is instrumental in moving the field from expert opinion toward robust, evidence-based decision-making, ultimately aiming to reduce overtreatment and preserve kidney function for patients with incidental, low-risk tumors.
Research Focus
Key Achievements
Top Papers
- 1
- 2